RPAM
LUNG icon

Rhenman & Partners Asset Management’s Pulmonx LUNG Stock Holding History

Rhenman & Partners Asset Management’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-25,000
Closed -$319K – 91
2023
Q4 		$319K Buy
+25,000
New +$260K 0.03% 84

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Rhenman & Partners Asset Management's LUNG Position: Q1 2024 in Review

Rhenman & Partners Asset Management sold out of Pulmonx (LUNG) in Q1 2024, closing a stake of 25,000 shares — an estimated $319K sold.

Rhenman & Partners Asset Management first reported a position in LUNG in Q4 2023 and held it in 1 quarter. The position peaked at $319K in Q4 2023. 118 funds tracked by Wall St. Rank hold LUNG as of Q1 2024.

  • Rhenman & Partners Asset Management reported no remaining Pulmonx position as of Q1 2024 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 25,000 Pulmonx shares in Q1 2024, an estimated $319K.
  • Rhenman & Partners Asset Management first reported a position in Pulmonx in Q4 2023 and held it in 1 quarter.
  • Rhenman & Partners Asset Management's Pulmonx position peaked at $319K in Q4 2023.
  • 118 funds tracked by Wall St. Rank held Pulmonx as of Q1 2024.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2024, filed 14 May 2024.